Patents by Inventor Iddo M. Gescheit
Iddo M. Gescheit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11419790Abstract: A transfer station for transferring a medical fluid between at least one supply container and at least one administration container of an infusion device is described. In an embodiment, the transfer station comprises at least one supply port configured for fluidic connection of the at least one supply container to the transfer station, and at least one exit port configured for fluidic connection of the at least one administration container to the transfer station. A transfer mechanism for automatically transferring a predetermined amount of medical fluid from the at least one supply container to the at least one administration container, and an electronic processing unit connected to an actuation means are provided with the transfer station. A processing unit controls the transfer mechanism and fluid transfer conditions according to a predetermined transfer demand entered by the actuation means.Type: GrantFiled: February 11, 2015Date of Patent: August 23, 2022Assignee: ROCHE DIABETES CARE, INC.Inventors: Ofer Yodfat, Illai J Gescheit, Iddo M. Gescheit
-
Patent number: 9919105Abstract: Devices, systems and methods for determining a recommended bolus dose of therapeutic fluid to be delivered to the body are disclosed. Such a recommended bolus dose may be provided by establishing an initial bolus dose for a user based on one or more first parameters relating to the user and adjusting (e.g., increasing or decreasing) this initial bolus dose amount based on one or more second user parameters by multiplying the initial bolus dose by one or more multiplier values that correlate to at least one of the second parameters and/or by adding or subtracting an absolute value of at least one of the second parameters from the initial bolus dose amount.Type: GrantFiled: September 16, 2010Date of Patent: March 20, 2018Assignee: Roche Diagnostics Operations, Inc.Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit
-
Patent number: 9597451Abstract: Embodiments of the present disclosure are directed to systems, devices/apparatuses and methods for assessing a residual insulin value for a user/patient. Such embodiments may be implemented by selecting a first value corresponding to a duration of insulin action; selecting a second value corresponding to a lock out time duration, selecting a first time period beginning at a time point T0 minus the first value and ending at the time point T0 minus the second value, selecting one or more boluses delivered during the first time period; for each of the one or more boluses selecting a corresponding residual insulin value estimated at the time point T0, computing the cumulative residual insulin value by summation of the corresponding residual insulin values.Type: GrantFiled: February 11, 2010Date of Patent: March 21, 2017Assignee: Roche Diagnostic Operations, Inc.Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit
-
Patent number: 9457145Abstract: Systems, devices and methods are presented in the subject disclosure for recommending an insulin dose adapted for use with an insulin delivery device. In some embodiments, the method may include receiving blood glucose (BG) data, determining one or more insulin sensitivity (IS) values associated with the BG data, and determining an insulin dose based on the determined one or more IS values. A system for carrying out such a method is also presented.Type: GrantFiled: January 20, 2011Date of Patent: October 4, 2016Assignee: Roche Diabetes Care, Inc.Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit
-
Patent number: 8971981Abstract: Disclosed is an assembly for use with a portable therapeutic device. The assembly includes a mounting housing securable to skin of a patient, and a cannula subcutaneously insertable through a passageway provided within the housing. The cannula is configured to be inserted subsequent to securing of the housing to the skin of the patient.Type: GrantFiled: July 31, 2008Date of Patent: March 3, 2015Assignee: Roche Diagnostics Operations, Inc.Inventors: Ofer Yodfat, Iddo M. Gescheit, Illai Gescheit
-
Patent number: 8641670Abstract: A device (1000) for delivering a therapeutic fluid (e.g. insulin) into a body of a patient are provided. In one aspect, the device can be implemented with a help of a patch unit (10) securable to a cradle unit (20) or to the body of the patient. The patch unit can employ a driving mechanism (120), a power source (210), a processor (110), a user interface (14) and a display(12). The processor can be adapted for controlling the driving mechanism by using one or more inputs. The inputs can corresponding to a basal rate and/or a bolus profile. The display can be adapted for displaying the inputs. The user interface can be adapted for adjusting the inputs.Type: GrantFiled: July 31, 2008Date of Patent: February 4, 2014Assignee: Roche Diagnostics Operations Inc.Inventors: Ofer Yodfat, Iddo M. Gescheit
-
Patent number: 8615281Abstract: Disclosed is a skin adherable device for monitoring analytes in interstitial fluid. The device includes an electromagnetic radiation emitting source and a transmitter for transmitting the electromagnetic radiation between the electromagnetic radiation emitting source and the interstitial fluid. The device further includes a detector, operating electronics and a power supply. The device may include a reusable part and a disposable part.Type: GrantFiled: November 20, 2008Date of Patent: December 24, 2013Assignee: Medingo Ltd.Inventors: Ofer Yodfat, Iddo M. Gescheit, Illai Gescheit, Ruthy Kaidar
-
Publication number: 20130030358Abstract: Systems, devices and methods are presented in the subject disclosure for recommending an insulin dose adapted for use with an insulin delivery device. In some embodiments, the method may include receiving blood glucose (BG) data, determining one or more insulin sensitivity (IS) values associated with the BG data, and determining an insulin dose based on the determined one or more IS values. A system for carrying out such a method is also presented.Type: ApplicationFiled: January 20, 2011Publication date: January 31, 2013Applicant: MEDINGO LTD.Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit
-
Publication number: 20120283694Abstract: Devices, systems and methods for determining a recommended bolus dose of therapeutic fluid to be delivered to the body are disclosed. Such a recommended bolus dose may be provided by establishing an initial bolus dose for a user based on one or more first parameters relating to the user and adjusting (e.g., increasing or decreasing) this initial bolus dose amount based on one or more second user parameters by multiplying the initial bolus dose by one or more multiplier values that correlate to at least one of the second parameters and/or by adding or subtracting an absolute value of at least one of the second parameters from the initial bolus dose amount.Type: ApplicationFiled: September 16, 2010Publication date: November 8, 2012Applicant: MENDINGO LTD.Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit
-
Publication number: 20120059352Abstract: Embodiments of the present disclosure are directed to systems, devices/apparatuses and methods for assessing a residual insulin value for a user/patient. Such embodiments may be implemented by selecting a first value corresponding to a duration of insulin action; selecting a second value corresponding to a lock out time duration, selecting a first time period beginning at a time point T0 minus the first value and ending at the time point T0 minus the second value, selecting one or more boluses delivered during the first time period; for each of the one or more boluses selecting a corresponding residual insulin value estimated at the time point T0, computing the cumulative residual insulin value by summation of the corresponding residual insulin values.Type: ApplicationFiled: February 11, 2010Publication date: March 8, 2012Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit
-
Publication number: 20110071765Abstract: Embodiments of the present disclosure are directed to methods, systems and devices for alleviating postprandial hyperglycemia, as well as to methods and devices for sustained medical infusion of fluids, using, for example, skin securable insulin dispensing systems/devices.Type: ApplicationFiled: May 14, 2009Publication date: March 24, 2011Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit
-
Publication number: 20100249558Abstract: Disclosed is a skin adherable device for monitoring analytes in interstitial fluid. The device includes an electromagnetic radiation emitting source and a transmitter for transmitting the electromagnetic radiation between the electromagnetic radiation emitting source and the interstitial fluid. The device further includes a detector, operating electronics and a power supply. The device may include a reusable part and a disposable part.Type: ApplicationFiled: November 20, 2008Publication date: September 30, 2010Inventors: Ofer Yodfat, Iddo M. Gescheit, Illai Gescheit, Ruthy Kaidar
-
Publication number: 20100145276Abstract: A device (1000) for delivering a therapeutic fluid (e.g. insulin) into a body of a patient are provided. In one aspect, the device can be implemented with a help of a patch unit (10) securable to a cradle unit (20) or to the body of the patient. The patch unit can employ a driving mechanism (120), a power source (210), a processor (110), a user interface (14) and a display(12). The processor can be adapted for controlling the driving mechanism by using one or more inputs. The inputs can corresponding to a basal rate and/or a bolus profile. The display can be adapted for displaying the inputs. The user interface can be adapted for adjusting the inputs.Type: ApplicationFiled: July 31, 2008Publication date: June 10, 2010Inventors: Ofer Yodfat, Iddo M. Gescheit
-
Publication number: 20100137695Abstract: Disclosed is an assembly for use with a portable therapeutic device. The assembly includes a mounting housing securable to skin of a patient, and a cannula subcutaneously insertable through a passageway provided within the housing. The cannula is configured to be inserted subsequent to securing of the housing to the skin of the patient.Type: ApplicationFiled: July 31, 2008Publication date: June 3, 2010Inventors: Ofer Yodfat, Iddo M. Gescheit, Illai Gesscheit
-
Publication number: 20090018406Abstract: A system and a method for determining an assessed carbohydrate to insulin ratio of a patient is described. The system and the method can comprise a memory component adapted for storing an initial set of values comprising at least one of a blood glucose level, a target blood glucose level, an insulin sensitivity, and, an estimated carbohydrate to insulin ratio. The system and the method can also comprise a bolus selection component adapted for selecting a test bolus corresponding to the determined initial set of values and a planned meal. In one implementation, the bolus selection component can receive bolus dose input from a user. In another implementation, the bolus selection component can estimate the bolus dose using a set of available inputs (e.g. the amount of carbohydrates in the planned meal). The system and the method can further comprise a user interface component adapted for receiving a confirmation that the test bolus has been administered to the patient.Type: ApplicationFiled: June 20, 2008Publication date: January 15, 2009Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit
-
Publication number: 20080234663Abstract: A method, apparatus and system for selecting a bolus dose of a drug in a drug delivery device is disclosed. The method comprises selecting the bolus dose from a pre-determined schedule of bolus doses, wherein each dose corresponds to a range of a body analyte levels.Type: ApplicationFiled: March 19, 2008Publication date: September 25, 2008Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit